title: Metrorrhagia after intravitreal injection of bevacizumab.
authors.forename: Eduardo B
authors.initials: EB
authors.lastname: Rodrigues
authors.forename: Helio
authors.initials: H
authors.lastname: Shiroma
authors.forename: Carsten H
authors.initials: CH
authors.lastname: Meyer
authors.forename: Maurício
authors.initials: M
authors.lastname: Maia
authors.forename: Michel E
authors.initials: ME
authors.lastname: Farah
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D007267:Injections; D008796:Metrorrhagia / Q000139:chemically induced*; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab